Şükran Köse

4.5k total citations
169 papers, 1.9k citations indexed

About

Şükran Köse is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Şükran Köse has authored 169 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Epidemiology, 45 papers in Hepatology and 41 papers in Infectious Diseases. Recurrent topics in Şükran Köse's work include Hepatitis B Virus Studies (48 papers), Hepatitis C virus research (41 papers) and Liver Disease Diagnosis and Treatment (27 papers). Şükran Köse is often cited by papers focused on Hepatitis B Virus Studies (48 papers), Hepatitis C virus research (41 papers) and Liver Disease Diagnosis and Treatment (27 papers). Şükran Köse collaborates with scholars based in Türkiye, United States and Iran. Şükran Köse's co-authors include Hossein Samadi Kafil, Khudaverdi Ganbarov, Sounkalo Dao, Aliye Mandıracıoğlu, Yusuf Özbel, Silvano Esposito, Hadis Fathizadeh, Parham Maroufi, Pourya Gholizadeh and Süheyla Serin Senger and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Biological Macromolecules and BMC Public Health.

In The Last Decade

Şükran Köse

151 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Şükran Köse Türkiye 22 657 584 287 236 177 169 1.9k
Jang Wook Sohn South Korea 29 991 1.5× 781 1.3× 121 0.4× 311 1.3× 70 0.4× 140 2.3k
Emil C. Reisinger Germany 29 880 1.3× 1.1k 1.9× 284 1.0× 427 1.8× 74 0.4× 191 3.3k
Gianluca Russo Italy 24 393 0.6× 460 0.8× 258 0.9× 80 0.3× 111 0.6× 111 1.6k
José Marı́a Eiros Bouza Spain 28 1.5k 2.2× 1.1k 1.8× 188 0.7× 500 2.1× 106 0.6× 301 3.3k
Radha Kanta Ratho India 23 558 0.8× 947 1.6× 365 1.3× 164 0.7× 82 0.5× 135 1.8k
Annalisa Saracino Italy 29 981 1.5× 1.5k 2.6× 285 1.0× 186 0.8× 149 0.8× 212 3.2k
Ki Tae Kwon South Korea 29 1.0k 1.5× 791 1.4× 68 0.2× 242 1.0× 45 0.3× 170 2.9k
Tom Snelling Australia 27 1.3k 1.9× 771 1.3× 153 0.5× 82 0.3× 477 2.7× 160 2.5k
Khitam Muhsen Israel 29 275 0.4× 1.1k 1.9× 163 0.6× 167 0.7× 384 2.2× 117 2.7k
Mayuko Saito Japan 33 708 1.1× 1.4k 2.5× 117 0.4× 335 1.4× 36 0.2× 129 3.2k

Countries citing papers authored by Şükran Köse

Since Specialization
Citations

This map shows the geographic impact of Şükran Köse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Şükran Köse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Şükran Köse more than expected).

Fields of papers citing papers by Şükran Köse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Şükran Köse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Şükran Köse. The network helps show where Şükran Köse may publish in the future.

Co-authorship network of co-authors of Şükran Köse

This figure shows the co-authorship network connecting the top 25 collaborators of Şükran Köse. A scholar is included among the top collaborators of Şükran Köse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Şükran Köse. Şükran Köse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Emiroğlu, Mustafa, et al.. (2025). Comparing Scoring Systems and Biomarkers For Mortality in Fournier Gangrene Patients. Bratislavské lekárske listy/Bratislava medical journal. 126(7). 1500–1508.
2.
Köse, Şükran, et al.. (2024). Exploring the Role of Long Non-Coding RNAs in Predicting Outcomes for Hepatitis B Patients. Asian Pacific Journal of Cancer Prevention. 25(12). 4313–4321.
3.
Köse, Şükran, et al.. (2024). Effects of Repeated Doses of the Vero Cell Vaccine (SARS-Cov-2 Inactivated Vaccine) on Renal Functions in Balb/C Albino Mice. Journal of Inflammation Research. Volume 17. 2851–2860. 1 indexed citations
4.
5.
Köse, Şükran, Tuba Dal, Rıza Aytaç Çeti̇nkaya, et al.. (2023). Molecular epidemiological investigation of carbapenem resistant Klebsiella pneumoniae isolated from intensive care unit patients of six geographical regions of Turkey. The Journal of Infection in Developing Countries. 17(10). 1446–1451. 2 indexed citations
6.
Ozma, Mahdi Asghari, Amin Abbasi, Sousan Akrami, et al.. (2022). Postbiotics as the key mediators of the gut microbiota-host interactions. Infezioni in Medicina. 30(2). 180–193. 42 indexed citations
7.
Singil, Sarp, et al.. (2022). İmmunsupresif Tedavi Alan Hastalarda Hepatit B Reaktivasyonu Riskinin Değerlendirilmesi. DergiPark (Istanbul University). 1(3). 112–116. 1 indexed citations
9.
Gholizadeh, Pourya, Mohammad Aghazadeh, Reza Ghotaslou, et al.. (2020). CRISPR- cas system in the acquisition of virulence genes in dental-root canal and hospital-acquired isolates of Enterococcus faecalis. Virulence. 11(1). 1257–1267. 27 indexed citations
10.
Gholizadeh, Pourya, Şükran Köse, Khudaverdi Ganbarov, et al.. (2020). How CRISPR-Cas System Could Be Used to Combat Antimicrobial Resistance. SHILAP Revista de lepidopterología. 5 indexed citations
11.
Köse, Şükran, et al.. (2020). The Course of COVID-19 in Four Patients with HIV During the Pandemic. Current HIV Research. 19(3). 286–291. 3 indexed citations
12.
Köse, Şükran, et al.. (2019). Hepatitis B seroprevalence in hematological oncology patients. The European Research Journal. 6(2). 87–91.
13.
Aşan, Ali, et al.. (2018). Nephrotoxicity rates related to colistin and evaluation of risk factors. The European Research Journal. 6(1). 62–66. 2 indexed citations
14.
Köse, Şükran, et al.. (2017). Hepatitis A, B, C and HIV seroprevalence among Syrian refugee children admitted to outpatient clinics.. PubMed. 25(4). 339–343. 16 indexed citations
15.
Köse, Şükran, et al.. (2014). Investigation of HIV-1 Primary Drug Resistance Mutations in Antiretroviral Therapy-Naive Cases. Mikrobiyoloji Bulteni. 48(4). 585–595. 4 indexed citations
16.
Köse, Şükran, et al.. (2011). Seroprevalence of hepatitis B and C viruses: Awareness and safe practices of hairdressers in Izmir — A survey. International Journal of Occupational Medicine and Environmental Health. 24(3). 275–82. 14 indexed citations
17.
Köse, Şükran, et al.. (2011). Tepecik Eğitim ve Araştırma Hastanesi'nde düşük düzeyde anti-hepatit C pozitifliği saptanan örneklerin HCV RNA düzeylerinin değerlendirilmesi. 68(4). 191–196.
18.
Yılmaz, Nisel, et al.. (2010). Yoğun bakım ünitesinde yatan hastaların kan kültürlerinde üreyen mikroorganizmalar, antibiyotik duyaklılıkları ve nozokomiyal bakteriyemi etkenleri. ANKEM Dergisi. 24(1). 12–19. 1 indexed citations
19.
Korkmaz, Metin, Şükran Köse, Aytül Sin, Ayşegül Taylan Özkan, & Ülgen Z. Ok. (2000). Serum levels of IgG, IgA, IgM, IgD and IgE in giardiasis patients.. Turkish Journal of Parasitology. 24(2). 101–105. 1 indexed citations
20.
Köse, Şükran, et al.. (1993). [Histopathological examinations of skin biopsy specimens from patients with acute HAV and HBV infections].. PubMed. 27(1). 56–61. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026